Clinical presentation of<unk>  usually does not occur until age 60, with the earliest recorded diagnosis and subsequent postmortem verification being age 28. Although men and women present with the disease, some analysis has shown a predominant appearance of<unk>  in women. Current calculations suggest that the prevalence of<unk>  is approximately 4.9 to 7.3 per 100,000 people. The prognosis for an individual diagnosed with<unk>  is death within approximately eight years, although some patients have been diagnosed over 17 years ago (2017) and are still in relatively good standing, but with serious debilitation such as dysphagia, and overall limb rigidity. The partial (or total) use of a feeding tube may be necessary and will help prevent aspiration pneumonia, primary cause of death in<unk> . Incontinence is common, as patients often can't express their need to go, due to eventual loss of speech. Therefore, proper hygiene is mandatory to prevent urinary tract infections.<unk>  research has been limited by the rarity of the disease and the lack of research criteria. It is estimated to affect 0.6-0.9 per 100,000 per year. Progressive supranuclear palsy (PSP) without<unk>  is estimated to be ten times more common.<unk>  represents roughly 4–6% of patients with Parkinsonism. Average age at disease onset is about 64, with the youngest confirmed onset being at age 43. There may be a slight female predominance.
Corticobasal degeneration
Progressive supranuclear palsy
Wallerian degeneration
White dot syndromes
Cerebellar degeneration
Central chromatolysis
Tauopathy
Multiple system atrophy